Correlation Between Fidelity MSCI and ARK Genomic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fidelity MSCI and ARK Genomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity MSCI and ARK Genomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fidelity MSCI Consumer and ARK Genomic Revolution, you can compare the effects of market volatilities on Fidelity MSCI and ARK Genomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity MSCI with a short position of ARK Genomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity MSCI and ARK Genomic.

Diversification Opportunities for Fidelity MSCI and ARK Genomic

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Fidelity and ARK is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity MSCI Consumer and ARK Genomic Revolution in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ARK Genomic Revolution and Fidelity MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity MSCI Consumer are associated (or correlated) with ARK Genomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ARK Genomic Revolution has no effect on the direction of Fidelity MSCI i.e., Fidelity MSCI and ARK Genomic go up and down completely randomly.

Pair Corralation between Fidelity MSCI and ARK Genomic

Given the investment horizon of 90 days Fidelity MSCI Consumer is expected to generate 0.45 times more return on investment than ARK Genomic. However, Fidelity MSCI Consumer is 2.22 times less risky than ARK Genomic. It trades about 0.1 of its potential returns per unit of risk. ARK Genomic Revolution is currently generating about 0.0 per unit of risk. If you would invest  6,403  in Fidelity MSCI Consumer on August 31, 2024 and sell it today you would earn a total of  3,274  from holding Fidelity MSCI Consumer or generate 51.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fidelity MSCI Consumer  vs.  ARK Genomic Revolution

 Performance 
       Timeline  
Fidelity MSCI Consumer 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Fidelity MSCI Consumer are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak forward indicators, Fidelity MSCI unveiled solid returns over the last few months and may actually be approaching a breakup point.
ARK Genomic Revolution 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ARK Genomic Revolution are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable forward-looking signals, ARK Genomic is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Fidelity MSCI and ARK Genomic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fidelity MSCI and ARK Genomic

The main advantage of trading using opposite Fidelity MSCI and ARK Genomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity MSCI position performs unexpectedly, ARK Genomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARK Genomic will offset losses from the drop in ARK Genomic's long position.
The idea behind Fidelity MSCI Consumer and ARK Genomic Revolution pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments